FDA-Inspected Site

Pharmco Laboratories Inc.

8 FDA inspections are on record for Pharmco Laboratories Inc. in Titusville, United States.

483· Form 483 issued

Titusville, United States · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 5 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-03-20.

At a glance

Inspections

8

Form 483s

5

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Mar 2025 – 20 Mar 2025Human Drugs483View 483 →
13 Sep 2021 – 22 Sep 2021Human Drugs483On file
24 Jun 2019 – 28 Jun 2019Foods & CosmeticsClean
9 Nov 2015 – 30 Nov 2015Human DrugsWLOn file
21 Jun 2012Not recorded483On file
14 Aug 2008Not recorded483On file
12 May 2006Not recordedClean
12 Sep 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

20 Mar 2025
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Damaris Y Hernandez, Michael Z Weigman

20 Mar 2025
21 CFR 211.192

Quality control unit review of records

Cited by Damaris Y Hernandez, Michael Z Weigman

20 Mar 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Damaris Y Hernandez, Michael Z Weigman

20 Mar 2025
21 CFR 211.63

Equipment Design, Size and Location

Cited by Damaris Y Hernandez, Michael Z Weigman

20 Mar 2025
21 CFR 211.67(b)(2)

Cleaning SOPs/schedules

Cited by Damaris Y Hernandez, Michael Z Weigman

Investigators

FDA investigators tied to this site in the record.

Michael Z Weigman1 insp.
Jason P Aun1 insp.
Ileana Barreto-Pettit1 insp.
Angela E Glenn1 insp.
Barbara T Carmichael1 insp.
Kelly I Anderson1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations3x
21 CFR 211.160(b)Cited across public-safe Form 483 observations2x
21 CFR 211.170(b)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.63Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.117(d)Cited across public-safe Form 483 observations1x
21 CFR 111.14(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.15(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.260(l)(4)Cited across public-safe Form 483 observations1x
21 CFR 111.35(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.35(b)(6)Cited across public-safe Form 483 observations1x
21 CFR 111.503Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 111.75(i)Cited across public-safe Form 483 observations1x
21 CFR 111.95(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 111.95(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Pharmco Laboratories Inc.'s 5 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites